- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03803709
Dietary Fiber Intake in Alcohol-dependent Patients
The alcohol problem affects 7.5% of the population in Europe and represents a major public health problem. Alcoholism is also a major cause of undernutrition. Diet is a major factor influencing the composition of the intestinal microbiota and previous studies, carried out at Saint-Luc clinics and catholic university of Louvain, show that alcoholic patients suffer from dysbiosis, that is a significant alteration of the gut microbiota. The investigator's preliminary studies, carried out at the Integrated Unit of Hepatology of Saint-Luc Clinics, have shown that alcohol represents more than 40% of total caloric intake in alcohol-dependent patients. In addition, alcoholic patients have an insufficient intake of dietary fiber, that is to say a contribution lower than the Belgian nutritional recommendations. Indeed, the Conseil Supérieur de la Santé recommends a total amount of dietary fiber equal to or greater than 25 grams per day to ensure correct intestinal function. Fructan-type dietary fiber (inulin and fructo-oligosaccharides) is found naturally in many fruits and vegetables (Jerusalem artichokes, asparagus, artichokes, onions, garlic, chicory roots, bananas). They are neither absorbed nor digested by human enzymes but fermented selectively by intestinal bacteria.
A good digestive tolerance to dietary fiber supplementation has been observed in healthy subjects as well as in obese patients, in previous studies conducted at catholic university of Louvain and Saint-Luc clinics. However, a nutritional rebalance via fiber supplementation and digestive fiber tolerance have never been tested in an alcohol-dependent population.
The primary objectives of this academic research project in nutrition, carried out in alcohol-dependent patients, are as follows:
- restore a nutritional balance as recommended by the Conseil Supérieur de la Santé via a dietary fiber intake
- to study digestive tolerance to fibers
- to study the intestinal and psychological well-being related to a fiber intake
Depending on the results obtained during the achievement of the primary objectives, the biological samples (blood, stool) collected during the study will be used to analyze the composition of the intestinal microbiota and the plasma markers associated with intestinal function.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Peter Stärkel, MD, PhD
- Phone Number: 003227642853
- Email: peter.starkel@uclouvain.be
Study Locations
-
-
-
Brussels, Belgium, 1200
- Recruiting
- Université Catholique de Louvain
-
Contact:
- Peter Stärkel, MD, PhD
- Phone Number: 003227642853
- Email: peter.starkel@uclouvain.be
-
Principal Investigator:
- Peter Stärkel, MD, PhD
-
Sub-Investigator:
- Nathalie Delzenne, PhD
-
Sub-Investigator:
- Sophie Leclercq, PhD
-
Sub-Investigator:
- Philippe de Timary, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male or female
- aged between 18 and 65
- caucasian
- French speaking
- alcohol drunk less than 48h before day 1
Exclusion Criteria:
- another addiction, except smoking
- psychiatric comorbidity on axe 1 of Diagnostic and Statistical Manual-IV
- antibiotic, probiotic or fibers recent (<2 months) treatment (or other molecule modifying intestinal transit)
- Non-steroidial anti-inflammatory drug or glucocorticoids recently taken (<1 month)
- obesity: Body Mass Index<30
- bariatric surgery
- Type 1 or 2 diabetes
- chronic inflammatory diseases (Crohn disease, coeliac disease, rheumatoid arthritis)
- cirrhosis or Advanced hepatic fibrosis (Fibroscan > or = F3)
- pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo
|
maltodextrine given at different dosis from day 3 to day 20
|
Experimental: inulin
|
inulin given at different dosis from day 3 to day 20
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in diet profile
Time Frame: on Day 2 and Day 19
|
This tool is based on the one adapted to alcoholic patients at Saint Luc Hospital. It consists of two parts to allow cross-checking of data (redundancy) and to measure separate information: General: it is implemented a Food Frequency Questionnaire (FFQ) in order to investigate the general diet profile. Daily: it resumes the sequencing of a full day which allows to verify the information previously obtained as well as to precisely identify the moments of consumption of alcoholic and non-alcoholic inputs. This 7-day recall will be carried out at two times: week T1 for reminder of the week before hospitalization then T2 for reminder of the week back home. In this last case, this anamnesis will be done by interview, but also on the basis of the diary filled by the patient in T2, in order to optimize the accuracy of the data. |
on Day 2 and Day 19
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alimentary book
Time Frame: From day 1 to day 21
|
The patient will have to fill in this book every day
|
From day 1 to day 21
|
Quantitative evaluation of intakes
Time Frame: on Day 2 and Day 19
|
The meals will be weighted before and after eating
|
on Day 2 and Day 19
|
Alimentation history
Time Frame: On day 21
|
This questionnaire makes it possible to further investigate the patient's diet before the episode of alcoholism in his adult and child life.
The aim is to assess whether it is closer to a healthy diet (Mediterranean diet or dash diet) or a Western diet type.
It is based on the recall technique and performed by a qualified dietician.
|
On day 21
|
Change in mood
Time Frame: on Day 2 and Day 19
|
Beck Depression Inventory (score 0-63).
Higher score indicates higher depression level.
|
on Day 2 and Day 19
|
Change in anxiety
Time Frame: on Day 2 and Day 19
|
State-Trait Anxiety Inventory (score 20-80).
Higher score indicates higher anxiety level.
|
on Day 2 and Day 19
|
Change in alcohol craving
Time Frame: on Day 2 and Day 19
|
Obsessive Compulsive Drinking Scale: a total score (= obsession + compulsion) (0-40) and 2 sub-scores (Obsession (0-20) and Compulsion (0-20)) are calculated.
Higher score indicates higher craving level.
|
on Day 2 and Day 19
|
Change in impulsivity
Time Frame: on Day 2 and Day 19
|
Urgency Premeditation Perseverance Sensation seeking impulsive behavior scale: score of different subscales are calculated: "urgency"(0-48), "lack of premeditation"(0-44), "lack of perseverance"(0-40), "sensation seeking"(0-48).
Higher score in the different subscales indicates higher impulsivity level.
|
on Day 2 and Day 19
|
Change in selective attention
Time Frame: on Day 2 and Day 19
|
William Lennox attention tests
|
on Day 2 and Day 19
|
Change in work memory
Time Frame: on Day 2 and Day 19
|
Brown-Peterson's tasks
|
on Day 2 and Day 19
|
Change in flexibility
Time Frame: on Day 2 and Day 19
|
Trail making test
|
on Day 2 and Day 19
|
Change in inhibition
Time Frame: on Day 2 and Day 19
|
Scoop's tasks
|
on Day 2 and Day 19
|
Change in decision making
Time Frame: on Day 2 and Day 19
|
Iowa gambling's task
|
on Day 2 and Day 19
|
Change in trauma
Time Frame: on Day 2 and Day 19
|
Post-traumatic diagnostic scale: calculation of score is complex and described in the related publication Hearn, M, Ceschi, G., Brillon, P, Fürst, G., & Van der Linden, M. (2012).
A French adaptation of the Post-traumatic Diagnostic scale.
Canadian Journal of Behavioural Science, 44, 16-28.
|
on Day 2 and Day 19
|
Change in intestine integrity
Time Frame: on Day 2 and Day 19
|
It will be determined by blood sample (LPS level)
|
on Day 2 and Day 19
|
Change in albumin, pre-albumin and zinc concentration
Time Frame: on Day 2 and Day 19
|
It will be determined by blood sample
|
on Day 2 and Day 19
|
Change in intestinal permeability
Time Frame: on Day 2 and Day 19
|
Patients will ingest 50microCurie of 51Chrome-Ethylenediamintetraacetic prepared in a Nutridrink®.
This molecule is not normally absorbed by the intestine except when there is an increase in intestinal permeability (paracellular passage following rupture of tight junctions).
The molecule is then filtered by the kidney and is found in the urine.
A 24h urine collection will be carried out to measure the radioactivity emitted by 51Chrome-Ethylenediamintetraacetic
|
on Day 2 and Day 19
|
Change in fecal albumin concentration
Time Frame: on Day 2 and Day 19
|
A stool sample will be collected to analyze a marker of intestinal permeability: fecal albumin
|
on Day 2 and Day 19
|
Intestinal permeability
Time Frame: On day 3
|
a duodenal biopsy will be collected and the expression of the tight junctions regulating the intestinal permeability will be analyzed by sectional immunofluorescence and quantitative Polymerase Chain reaction
|
On day 3
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Amadieu C, Maccioni L, Leclercq S, Neyrinck AM, Delzenne NM, de Timary P, Stärkel P. Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: A pilot randomized, double-blind, placebo-controlled study. EBioMedicine. 2022 Jun;80:104033. doi: 10.1016/j.ebiom.2022.104033. Epub 2022 Apr 28.
- Amadieu C, Coste V, Neyrinck AM, Thijssen V, Leyrolle Q, Bindels LB, Piessevaux H, Stärkel P, de Timary P, Delzenne NM, Leclercq S. Restoring an adequate dietary fiber intake by inulin supplementation: a pilot study showing an impact on gut microbiota and sociability in alcohol use disorder patients. Gut Microbes. 2022 Jan-Dec;14(1):2007042. doi: 10.1080/19490976.2021.2007042.
- Amadieu C, Leclercq S, Coste V, Thijssen V, Neyrinck AM, Bindels LB, Cani PD, Piessevaux H, Starkel P, de Timary P, Delzenne NM. Dietary fiber deficiency as a component of malnutrition associated with psychological alterations in alcohol use disorder. Clin Nutr. 2021 May;40(5):2673-2682. doi: 10.1016/j.clnu.2021.03.029. Epub 2021 Mar 30.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 190616V1
- 2017/04JUL/354 (Other Identifier: Ethics Committee CEHF)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcoholism
-
Yale UniversityCompletedFamilial Alcoholism VulnerabilityUnited States
-
Yonsei UniversityTerminated
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingFamilial Alcoholism VulnerabilityUnited States
-
University of Southern DenmarkActive, not recruitingGeneral Practice | Alcohol Abuse Alcoholism | Screening and Brief InterventionDenmark
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedEffects of Family History of Alcoholism and Sex on Alcohol AnalgesiaUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcoholic Liver Disease | Alcoholism,United States
-
Khoo Teck Puat HospitalNot yet recruitingEmergencies | Alcohol Use Disorder | Alcoholism and Alcohol Abuse
-
National Institute on Drug Abuse (NIDA)The Peter G. Dodge Foundation (PGDF)Completed
-
Virginia Commonwealth UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Yale University; University...CompletedAlcoholismUnited States
-
University of Sao PauloCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsEnrolling by invitation
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States